October 16, 2020
According to the research report titled ‘Vitamin K2 Market Share, Size, Trends, Industry Analysis Report By Source; By Product; By Application; By Regions, Segments & Forecast, 2020 – 2026’ available with Market Study Report, global vitamin K2 market is anticipated to reflect a valuation of USD 290.3 million by the year 2026.
Industry experts claim that growing concerns regarding infant mortality coupled with increasing occurrence of vitamin deficiency in humans are bolstering the growth of global vitamin K2 market size. Rising prevalence of osteoporosis, escalating demand for calcium deficiency compensation, and beneficial characteristics of the product such as enhanced taste and texture as well as increased shelf life are further fueling the industry expansion.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2963843/
Additionally, surging adoption of the product across the pharmaceutical industry, growing geriatric population, and increasing efforts of industry players to develop innovative products are positively swaying the global vitamin K2 market dynamics.
Based on source type, global vitamin K2 industry is split into synthetic and natural segments, among which the latter is projected to witness substantial expansion through 2026. Favorable government regulations pertaining to drug testing procedures in the pharmaceutical sector are fostering the growth of the natural segment.
With regards to application scope, global vitamin K2 market share from nutraceuticals & food application segment is predicted to grow significantly over the forecast period. Factors such as growing health awareness, evolving standard of living, and increasing disposable income are propelling the expansion of the segment.
From a regional frame of reference, North America accounted for a majority share of worldwide vitamin K2 market in the year 2019 and is expected to show similar growth through 2026. On the other hand, Asia-Pacific is also expected to emerge as a major growth avenue for the overall industry during the study period, owing to rising consumption of functional food products in India, China, and Australia.
The report states that vitamin K2 market in Middle East & Africa is also anticipated to record considerable expansion through 2026, on account of favorable government initiatives such as health and wellness campaigns.
The organizations that define the global vitamin K2 industry trends are GeneFerm Biotechnology Co. Ltd., Kyowa Hakko Bio Co. Ltd., Frutarom Industries Ltd., Viridis Biopharma Private Limited, Seebio Biotech (Shanghai) Co. Ltd., NattoPharma ASA, Gnosis S.p.A., Koninklijke DSM NV, DuPont Nutrition & Biosciences, and Kappa Bioscience AS.